The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most research has focused on developing peptide multi-agonists as most o...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Korean Society of Lipid and Atherosclerosis
2023-09-01
|
| Schriftenreihe: | Journal of Lipid and Atherosclerosis |
| Schlagworte: | |
| Online-Zugang: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.3.213&code=9992JLA&vmode=FULL |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
